Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients
1 other identifier
interventional
15
1 country
1
Brief Summary
Decreased bowel function and loss of appetite in patients who underwent pancreaticobiliary surgery contribute impaired nutritional status in postoperative period. It can also affect perioperative and oncologic outcomes negatively. Therefore it is important to improve nutritional status in postoperative period by supply tailor-made optimal diets. The investigators have developed customized postoperative diets and products for pancreaticobiliary cancer patients. The investigators expect that nutritional supplement for pancreaticobiliary patients will increase the food intake rate and contribute a improvement of perioperative outcomes and even oncologic outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2017
CompletedFirst Submitted
Initial submission to the registry
September 18, 2017
CompletedFirst Posted
Study publicly available on registry
September 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 11, 2018
CompletedJanuary 15, 2019
January 1, 2019
10 months
September 18, 2017
January 14, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
Food Intake Rate(%) for postoperative diet
Diet Intake Rate(%)
Pre-operation
Food Intake Rate(%) for postoperative diet
Diet Intake Rate(%)
1 day before discharging
Food Intake Rate(%) for postoperative diet
Diet Intake Rate(%)
1 week after discharging (first outpatient follow up)
Study Arms (2)
experimental group
EXPERIMENTALcontrol group
ACTIVE COMPARATORInterventions
Routine post-op care + Nutritional supplement by specific product
Eligibility Criteria
You may qualify if:
- Adult (age more than 19)
- Pancreaticobiliary cancer patient who is scheduled pancreaticoduodenectomy or distal pancreatectomy
- Pancreatic cancer / Duodenal cancer / Distal bile duct cancer / Ampulla of Vater cancer
You may not qualify if:
- Patient who denied clinical trial
- Diabetes Mellitus(DM) patient with DM complication
- Hyperlipidemia patient with vascular co-morbidity
- Impaired renal function or renal failure (GFP\<70%)
- Poor nutritional status (PG-SGA grade C)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine
Seoul, 03722, South Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2017
First Posted
September 26, 2017
Study Start
September 4, 2017
Primary Completion
July 11, 2018
Study Completion
July 11, 2018
Last Updated
January 15, 2019
Record last verified: 2019-01